文献速递心脑血管急症呼吸衰竭与机械通气

COPD急性加重史与心肌梗死及肺栓塞风险

Exacerbation History and Risk of Myocardial Infarction and Pulmonary Embolism in COPD.
PubMed 文献 · Chest · 2024-07-31
一句话结论在COPD患者中,急性加重次数和严重程度与远期心肌梗死和肺栓塞风险呈梯度相关,重度加重后风险更高。

研究基于瑞典国家气道登记库2014年1月至2022年6月66,422例≥30岁、肺功能数据完整的COPD患者,按基线前一年中度(口服糖皮质激素处方)和重度(住院)急性加重分类,随访至2022年12月,累计>265,000患者年,最长随访9年,采用Fine-Gray竞争风险模型计算亚分布风险比。与基线期无急性加重相比,急性加重次数和严重程度与心肌梗死和肺栓塞的长期风险呈梯度升高相关:1次中度加重对应心肌梗死亚分布HR 1.10(95%CI 0.97-1.24)、肺栓塞亚分布HR 1.33(95%CI 1.11-1.60);≥2次重度加重对应心肌梗死亚分布HR 1.82(95%CI 1.36-2.44)、肺栓塞亚分布HR 2.62(95%CI 1.77-3.89)。时间限制性随访敏感性分析显示,随访第一年关联更强,随时间推移减弱。

要点

  • 与基线期无COPD急性加重相比,1次中度加重者心肌梗死亚分布HR 1.10(95%CI 0.97-1.24),肺栓塞亚分布HR 1.33(95%CI 1.11-1.60)。
  • 与基线期无COPD急性加重相比,≥2次重度加重者心肌梗死亚分布HR 1.82(95%CI 1.36-2.44),肺栓塞亚分布HR 2.62(95%CI 1.77-3.89)。
  • 急性加重次数和严重程度与心肌梗死和肺栓塞长期风险呈梯度升高相关。
  • 时间限制性随访敏感性分析显示,随访第一年关联更强,随时间推移减弱。

适用人群与场景

  • 瑞典国家气道登记库中≥30岁、COPD原发诊断且肺功能数据完整的患者,纳入时间为2014年1月至2022年6月。
  • 按基线前一年中度(口服糖皮质激素处方)和重度(住院)COPD急性加重分类,随访至2022年12月,最长随访9年。

研究设计与关键结果

  • 研究类型为基于瑞典国家气道登记库的真实世界队列,纳入66,422例≥30岁COPD患者,累计>265,000患者年,最长随访9年。
  • 与基线期无COPD急性加重相比,1次中度加重者心肌梗死亚分布HR 1.10(95%CI 0.97-1.24),肺栓塞亚分布HR 1.33(95%CI 1.11-1.60)。
  • 与基线期无COPD急性加重相比,≥2次重度加重者心肌梗死亚分布HR 1.82(95%CI 1.36-2.44),肺栓塞亚分布HR 2.62(95%CI 1.77-3.89)。
  • 急性加重次数和严重程度与心肌梗死和肺栓塞长期风险呈梯度升高相关。
  • 时间限制性随访敏感性分析显示,随访第一年关联更强,随时间推移减弱。

证据类型、等级与局限

  • 证据类型:基于瑞典国家气道登记库的真实世界队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute exacerbations (AEs) of COPD are increasingly recognized as episodes of heightened risk of cardiovascular events. It is not known whether exacerbation history is differentially associated with future myocardial infarction (MI) or pulmonary embolism (PE).

RESEARCH QUESTION: Is the number and severity of AEs of COPD associated with increased risk of MI or PE in a real-life cohort of patients with COPD?

STUDY DESIGN AND METHODS: We identified a cohort of 66,422 patients (≥ 30 years of age) with a primary diagnosis of COPD in the Swedish National Airway Register from January 2014 to June 2022, with complete data on lung function. Patients were classified by moderate (prescription of oral corticosteroids) and severe (hospitalization) exacerbations the year before index date and were followed until December 2022 for hospitalization or death from MI or PE, corresponding to > 265,000 patient-years, with a maximum follow-up time of 9 years. Competing risk regression, according to the Fine-Gray model, was used to calculate subdistribution hazard ratios with 95% CIs.

RESULTS: Compared with no AEs of COPD in the baseline period, AE of COPD number and severity were associated with increased long-term risk of both MI and PE in a gradual fashion, ranging from a subdistribution hazard ratio of 1.10 (95% CI, 0.97-1.24) and 1.33 (95% CI, 1.11-1.60), respectively, for one moderate exacerbation, to 1.82 (95% CI, 1.36-2.44) and 2.62 (95% CI, 1.77-3.89), respectively, for two or more severe exacerbations. In a time-restricted follow-up sensitivity analysis, the associations were stronger during the first year of follow-up and diminished over time.

INTERPRETATION: The risk of MI and PE increased with the frequency and severity of AEs of COPD in this large, real-life cohort of patients with COPD.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Wallström O, Stridsman C, Lindberg A, et al. Exacerbation History and Risk of Myocardial Infarction and Pulmonary Embolism in COPD. Chest. 2024. PMID: 39094732. doi:10.1016/j.chest.2024.07.150

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。